On-Demand Webinar: Meeting Modern Data Integrity and Compliance Requirements

On-Demand Webinar: Successful Tech Transfer and Validation for Your Pharmaceutical Products

On-Demand Webinar: Successful Technology Transfer and Validation for Your Pharmaceutical Products

On-Demand Webcast: Role of Information Systems in Biopharma Product & Process Development

Informatics -- the science of computer information systems -- are playing an increasingly important role in the complex arena of biopharmaceutical product and process development.

On-Demand Webcast: Laboratory Operations Management

How to Advance Product Quality, Compliance, and Efficiency

On-Demand Webcast: State of Pharmaceutical Industry Raw Material Identification

Raw material identification is a necessary step for ensuring cGMP compliance and for ensuring quality pharmaceutical products. However, where are we as an industry in conducting this necessary operation and quickly and accurately as possible at the lowest cost?

BW Tek - Raman Spectroscopy

BW Tek - Raman Spectroscopy : B&W Tek offers six educational videos on different methods of spectroscopy.

AAPS 2012: Brookfield Engineering's Powder Flow Tester

PM's Sr. Digital Editor, Michele V. Wagner discuss Brookfield Engineering's Powder Flow Tester with Global Marketing Manager, Bob McGregor, at the 2012 AAPS Meeting in Chicago.

AAPS 2012: Brookfield Engineering's CT3 Tester

Bob McGregor, Brookfield Engineering's Global Marketing Manager, demonstrates the Texture Analyzer, CT3 Tablet Tester at the 2012 AAPS Show in Chicago.

On-Demand Webinar: Speeding Time to Market: Inside Tomorrow's Biopharma Manufacturing Facility

Hear from insiders how modular construction, new production platforms and single-use technology are reducing the risk, and time, required for new biopharmaceutical manufacturing facility construction and startup. Learn true cost vs benefits, and distinguish between myth and reality in terms of equipment and platform capabilities and versatility. Manufacturing floor issues will also be discussed in depth, individual facility installations will be analyzed, sharing best practices and lessons learned.

Interphex 2012: Sanimatic's Latest in Cleaning Equipment Technology

Sani-matic's Chris McNulty, Director of Global Sales, discusses the latest in cleaning equipment technologies at the 2012 Interphex Show in New York City.

3M Purification: Expanding Its Wheel of Solutions

Biopharma solution providers are increasingly being asked to provide broad, scalable processing offerings. At Interphex 2012, Paul Lubas, senior marketing manager for 3M Purification, talks about how his company has expanded upon its traditional life sciences product families to now include a diverse "wheel" of solutions.

Emerson Process Management's Chris Amstutz on PAT & QbD

Pharmaceutical Manufacturing Editor in Chief Agnes Shanley discusses trends in the industry's use of PAT and QbD with Emerson Process Management's Director of Life Sciences Chris Amstutz. The industry has moved beyond "kicking the tires" of QbD, Amstutz says.

INTERPHEX 2012: Alkermes Expands Its Core Capabilities and Emphasizes Compliance

At Interphex 2012, Jim Botkin, Senior VP of Operations for Alkermes plc, discusses the extent of his organization's services and capabilities following the recent merger with Elan Drug Technologies. Botkin also discusses the importance of risk-based compliance to the success of any contract partnership. "GMP is good business," he says.

INTERPHEX 2012: Burkert's Fluid Control Systems

Pharmaceutical Manufacturing's Paul Thomas discusses the most recent fluid control system technologies with Burkert Field Segment Manager, Rick Zinkowski. For more information visit www.burkert-usa.com.

Central Research Labs: An Emphasis on Safety and Dexterity

At Interphex 2012, Sean Peterson of Central Research Laboratories demonstrates his company's latest technologies for glove boxes, transfer ports, and isolation. The emphasis is on operator safety and dexterity, he tells Pharmaceutical Manufacturing's Michele V. Wagner.

Im-press-ive: A Look at Fette's New FE55

At Interphex 2012, Matt Bundenthal of Fette Compacting America shows off the company's new FE55 tablet press. The product was designed with the operator in mind, to simplify changeover, operations, and maintenance. In addition, the machine's automation capabilities far exceed what was available in the past, Bundenthal notes.

FlexFactory Gains Traction Across Pharma

At Interphex 2012, Xcellerex founder and CTO Parrish Galliher talks about the drug industry's adoption of his company's FlexFactory technology since it was commercialized a few years ago. Four FlexFactories have now been sold worldwide, Galliher says, by companies in different regions and with diverse needs. Speaking with Pharmaceutical Manufacturing's Paul Thomas, Galliher provides a complete, end-to-end tour of FlexFactory.

Interphex 2012: Foster Wheeler Biokinetics Keeps Its Eyes on Future Drug Manufacturing Facilities

At Interphex 2012, Daniel Lachapelle, managing director for Foster Wheeler Biokinetics, provides an update on his company's core competencies in engineering, design, construction, and validation of biopharmaceutical facilities. Speaking with Pharmaceutical Manufacturing's Senior Editor Paul Thomas, he shares pain points that life sciences manufacturers are experiencing in meeting the needs of today's global, yet local drug markets.

Soft Sell: Patheon Introduces P-Gels

At Interphex 2012, Patheon's Geoffrey Glass and Softigel's Alvaro Franco discuss their companies' new collaboration to offer customers P-Gels, or prescription softgels and other new technologies that have not previously been available within pharmaceutical contract manufacturing. New, innovative products include varieties of gelatin-coated tablets, VeggieGels, and twist-off capsules.

Webcast: Facilities of the Future, Today

Join us for a review and moderated discussion of the issues and technologies driving new pharmaceutical manufacturing facility design and construction, both in the U.S. and in growing Asian markets. Among the questions, in the U.S. are: where are the facilities being built and how will that affect industry employment trends? How are they being designed?